http://jcps.bjmu.edu.cn

中国药学(英文版) ›› 2023, Vol. 32 ›› Issue (12): 1037-1038.

• 【新闻】 • 上一篇    下一篇

张亮仁/刘振明团队在基于化学反应的药物分子全新设计方面取得进展

北京大学药学院 天然药物及仿生药物全国重点实验室   

  1. 北京大学药学院 天然药物及仿生药物全国重点实验室
  • 收稿日期:2023-12-10 修回日期:2023-12-11 接受日期:2023-12-11 出版日期:2024-01-04 发布日期:2024-01-06

The research team of Prof. Liangren Zhang and Prof. Zhenming Liu made progress in the novel design of drug molecules based on chemical reactions

State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center   

  1. State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University Health Science Center
  • Received:2023-12-10 Revised:2023-12-11 Accepted:2023-12-11 Online:2024-01-04 Published:2024-01-06

摘要:

2023年12月5日, 北京大学药学院天然药物及仿生药物全国重点实验室张亮仁教授/刘振明研究员团队在Nature Machine Intelligence上在线发表了题为” Bridging the gap between chemical reaction pretraining and conditional molecule generation with a unified model” 的研究论文, 针对化学反应表征和可合成的分子生成方法提出了通用的深度学习框架。

Abstract: The research team of Prof. Liangren Zhang and Prof. Zhenming Liu made progress in the novel design of drug molecules based on chemical reactions.

Supporting: